Explore 3 Stock Ideas & Industry Insights Download Free Report

Banyan Corp

Healthcare US BNYN

0.0002USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap0.00005M
  • Volume5
  • P/E Ratio-
  • Dividend Yield3.95%
  • EBITDA-1.56984M
  • Revenue TTM3.48M
  • Revenue Per Share TTM1.53
  • Gross Profit TTM 5.00M
  • Diluted EPS TTM-2.0

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly
Date 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Income before tax -5.48302M -4.08310M -4.64582M -2.64451M
Minority interest - - - -
Net income -5.48302M -4.08310M -4.64582M -2.81716M
Selling general administrative 7.55M 6.99M 2.47M 2.85M
Selling and marketing expenses - - - -
Gross profit 5.00M 5.45M 0.99M 0.36M
Reconciled depreciation - - - -
Ebit -2.75402M -1.89778M -2.52168M -2.49548M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -2.75402M -1.89778M -2.52168M -2.49548M
Other operating expenses - 0.35M 0.35M -
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.00000M 0.00000M 0.00000M 0.00000M
Total revenue 5.00M 5.45M 1.09M 0.47M
Total operating expenses 7.76M 7.35M 3.61M 2.96M
Cost of revenue 0.00000M 0.00000M 0.10M 0.11M
Total other income expense net -2.72900M -2.18532M -2.12414M -0.14904M
Discontinued operations - - - -0.17265M
Net income from continuing ops -5.48302M -4.08310M -4.64582M -2.64451M
Net income applicable to common shares -5.48302M -4.08310M -4.64582M -2.81716M
Preferred stock and other adjustments - - - -
Breakdown 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly
Date 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Total assets 4.50M 5.23M 1.86M 1.05M
Intangible assets 0.16M 0.34M 0.66M -
Earning assets - - - -
Other current assets 0.14M 0.12M - -
Total liab 4.52M 4.44M 2.56M 2.44M
Total stockholder equity -0.01551M 0.79M -0.70151M -1.73211M
Deferred long term liab 0.02M 0.08M 0.16M -
Other current liab 0.32M 0.47M 0.59M 1.22M
Common stock 17.72M 15.40M 16.08M 9.96M
Capital stock - - - -
Retained earnings -26.31699M -20.83397M -16.75087M -11.74782M
Other liab - - - -
Good will 1.82M 1.82M - -
Other assets 0.47M 0.76M 0.89M 0.97M
Cash 0.05M 0.13M 0.00221M 0.00094M
Cash and equivalents - - - -
Total current liabilities 2.09M 2.38M 1.59M 2.04M
Current deferred revenue - - - -
Net debt - - - -
Short term debt 0.08M 3.02M 0.15M 0.78M
Short long term debt 0.08M 3.02M 0.15M 0.78M
Short long term debt total - - - -
Other stockholder equity -0.00998M -0.02530M -0.02623M 0.05M
Property plant equipment 0.06M 0.09M - -
Total current assets 1.99M 2.22M 0.31M 0.08M
Long term investments 0.44M 0.67M 0.73M -
Net tangible assets -2.00087M -1.36716M -1.36068M -1.73211M
Short term investments - - - -
Net receivables 1.80M 1.97M 0.31M 0.05M
Long term debt 2.40M 2.00M 0.97M 0.40M
Inventory - - - -
Accounts payable 0.45M 0.52M 0.54M 0.37M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total - - - -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Type yearly yearly yearly yearly
Date 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Investments 0.28M 0.06M 0.02M -
Change to liabilities 0.06M 0.20M 0.51M 0.05M
Total cashflows from investing activities 0.25M -1.76683M -0.67502M -0.67502M
Net borrowings 1.48M 2.70M 1.66M 0.36M
Total cash from financing activities 1.48M 2.73M 1.82M 1.08M
Change to operating activities -0.01634M -0.06577M 0.02M 0.02M
Net income -5.48302M -4.08310M -4.64582M -2.81716M
Change in cash -0.07741M 0.13M 0.00126M -0.00926M
Begin period cash flow - - - -
End period cash flow - - - -
Total cash from operating activities -1.81046M -0.83668M -1.14437M -1.08459M
Issuance of capital stock - - - -
Depreciation 0.27M 0.49M 0.18M 0.02M
Other cashflows from investing activities 0.28M 0.05M 0.02M 0.02M
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables 0.10M 0.37M -0.21313M -0.02275M
Sale purchase of stock - 0.03M 0.16M 0.88M
Other cashflows from financing activities - - - -0.16672M
Change to netincome 1.37M 0.68M 1.51M 1.62M
Capital expenditures 0.03M 0.00108M 0.00108M 0.00108M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow - - - -

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BNYN
Banyan Corp
- -% 0.0002 - - - - 0.16 -0.528
HCA
HCA Healthcare, Inc.
9.93 2.63% 386.92 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.17 1.50% 11.47 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-0.15 3.30% 4.40 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.

Banyan Corp

9025 Wilshire Boulevard, Beverly Hills, CA, United States, 90211

  • 800-808-0899
  • Employees : 20

Key Executives

Name Title Year Born
Mr. Michael J. Gelmon LL.B. Chairman & CEO 1965
Mr. Cory H. Gelmon Pres, COO, CFO, Principal Accounting Officer, Chief Legal Officer, Sec. & Director 1960

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.